STOCK TITAN

Pfizer Invites Public to View and Listen to Webcast of Pfizer Discussion at Healthcare Conference

Rhea-AI Impact
(Low)
Rhea-AI Sentiment
(Positive)
Tags
conferences

Pfizer Inc. (NYSE: PFE) has announced a public webcast featuring David Denton, Chief Financial Officer and Executive Vice President, at the Morgan Stanley 22nd Annual Global Healthcare Conference on September 4, 2024, at 8:30 a.m. EDT. Investors and the public can access the webcast through www.pfizer.com/investors.

The transcript and replay will be available on Pfizer's website within 24 hours after the live discussion and will remain accessible for at least 90 days. This event aligns with Pfizer's commitment to transparency and its mission to deliver breakthroughs that change patients' lives. As a leading biopharmaceutical company, Pfizer focuses on developing innovative medicines and vaccines, collaborating globally to improve healthcare access and affordability.

Pfizer Inc. (NYSE: PFE) ha annunciato un webcast pubblico con David Denton, Chief Financial Officer e Vicepresidente Esecutivo, durante il 22° Convegno Annuale Globale sulla Salute di Morgan Stanley il 4 settembre 2024, alle 8:30 a.m. EDT. Gli investitori e il pubblico possono accedere al webcast tramite www.pfizer.com/investors.

La trascrizione e la registrazione saranno disponibili sul sito web di Pfizer entro 24 ore dopo la discussione dal vivo e rimarranno accessibili per almeno 90 giorni. Questo evento è in linea con l'impegno di Pfizer per la trasparenza e la sua missione di fornire scoperte che cambiano la vita dei pazienti. In qualità di azienda bi-farmaceutica leader, Pfizer si concentra sullo sviluppo di medicinali e vaccini innovativi, collaborando a livello globale per migliorare l'accesso e l'affordabilità della sanità.

Pfizer Inc. (NYSE: PFE) ha anunciado un webcast público con David Denton, Director Financiero y Vicepresidente Ejecutivo, en la 22ª Conferencia Anual Global de Salud de Morgan Stanley el 4 de septiembre de 2024, a las 8:30 a.m. EDT. Los inversores y el público pueden acceder al webcast a través de www.pfizer.com/investors.

La transcripción y la repetición estarán disponibles en el sitio web de Pfizer dentro de las 24 horas posteriores a la discusión en vivo y permanecerán accesibles durante al menos 90 días. Este evento se alinea con el compromiso de Pfizer con la transparencia y su misión de ofrecer innovaciones que cambian la vida de los pacientes. Como una empresa biofarmacéutica líder, Pfizer se centra en el desarrollo de medicamentos y vacunas innovadores, colaborando a nivel global para mejorar el acceso y la asequibilidad en la atención médica.

화이자 주식회사 (NYSE: PFE)데이비드 덴턴, 최고재무책임자이자 이그제큐티브 부사장이 모건 스탠리 제22회 연례 글로벌 헬스케어 컨퍼런스에서 2024년 9월 4일 오전 8시 30분 EDT에 공개 웹캐스트를 진행한다고 발표했습니다. 투자자 및 대중은 www.pfizer.com/investors를 통해 웹캐스트에 접근할 수 있습니다.

토론 생중계 후 24시간 이내에 화이자의 웹사이트에서 녹취록과 다시 보기가 제공되며, 최소 90일 동안 접근할 수 있습니다. 이 행사는 화이자의 투명성에 대한 약속과 환자들의 삶을 변화시키는 혁신을 제공하려는 사명을 반영합니다. 선도적인 생물제약 회사로서 화이자는 혁신적인 의약품과 백신 개발에 집중하고 있으며, 건강 관리 접근성과 비용 효율성을 개선하기 위해 전 세계적으로 협력하고 있습니다.

Pfizer Inc. (NYSE: PFE) a annoncé un webcast public avec David Denton, directeur financier et vice-président exécutif, lors de la 22e Conférence Annuelle Mondiale sur la Santé de Morgan Stanley le 4 septembre 2024 à 8h30 EDT. Les investisseurs et le public peuvent accéder au webcast via www.pfizer.com/investors.

La transcription et la rediffusion seront disponibles sur le site de Pfizer dans les 24 heures suivant la discussion en direct et resteront accessibles pendant au moins 90 jours. Cet événement s'inscrit dans l'engagement de Pfizer en faveur de la transparence et sa mission de fournir des avancées qui changent la vie des patients. En tant qu'entreprise biopharmaceutique de premier plan, Pfizer se concentre sur le développement de médicaments et de vaccins innovants, collaborant à l'échelle mondiale pour améliorer l'accès et l'accessibilité des soins de santé.

Pfizer Inc. (NYSE: PFE) hat einen öffentlichen Webcast angekündigt, in dem David Denton, Chief Financial Officer und Executive Vice President, beim 22. jährlichen globalen Gesundheitskonferenz von Morgan Stanley am 4. September 2024 um 8:30 Uhr EDT sprechen wird. Investoren und die Öffentlichkeit können über www.pfizer.com/investors auf den Webcast zugreifen.

Das Transkript und die Wiederholung werden innerhalb von 24 Stunden nach der Live-Diskussion auf der Website von Pfizer verfügbar sein und mindestens 90 Tage lang zugänglich bleiben. Diese Veranstaltung steht im Einklang mit Pfizers Engagement für Transparenz und seiner Mission, Durchbrüche zu liefern, die das Leben der Patienten verändern. Als führendes biopharmazeutisches Unternehmen konzentriert sich Pfizer auf die Entwicklung innovativer Medikamente und Impfstoffe und arbeitet weltweit zusammen, um den Zugang zur Gesundheitsversorgung zu verbessern und deren Erschwinglichkeit zu steigern.

Positive
  • None.
Negative
  • None.

NEW YORK--(BUSINESS WIRE)-- Pfizer Inc. (NYSE: PFE) invites investors and the general public to view and listen to a webcast of a discussion with David Denton, Chief Financial Officer, Executive Vice President, at the Morgan Stanley 22nd Annual Global Healthcare Conference on Wednesday, September 4, 2024 at 8:30 a.m. EDT.

To view and listen to the webcast, visit our web site at www.pfizer.com/investors. Information on accessing and registering for the webcast will be available at www.pfizer.com/investors beginning today.

The transcript and webcast replay of the discussion will be made available on our web site at www.pfizer.com/investors within 24 hours after the end of the live discussion and will be accessible for at least 90 days.

About Pfizer: Breakthroughs That Change Patients’ Lives

At Pfizer, we apply science and our global resources to bring therapies to people that extend and significantly improve their lives. We strive to set the standard for quality, safety and value in the discovery, development and manufacture of health care products, including innovative medicines and vaccines. Every day, Pfizer colleagues work across developed and emerging markets to advance wellness, prevention, treatments and cures that challenge the most feared diseases of our time. Consistent with our responsibility as one of the world's premier innovative biopharmaceutical companies, we collaborate with health care providers, governments and local communities to support and expand access to reliable, affordable health care around the world. For 175 years, we have worked to make a difference for all who rely on us. We routinely post information that may be important to investors on our website at www.Pfizer.com. In addition, to learn more, please visit us on www.Pfizer.com and follow us on X at @Pfizer and @Pfizer News, LinkedIn, YouTube and like us on Facebook at Facebook.com/Pfizer.

Disclosure Notice: The webcast may include forward-looking statements about, among other things, expectations for our product pipeline, in-line products and product candidates, including anticipated regulatory submissions, data read-outs, study starts, approvals, launches, clinical trial results and other developing data, revenue contribution and projections, potential pricing and reimbursement, potential market dynamics, size and utilization rates, growth, performance, timing of exclusivity and potential benefits; our anticipated operating and financial performance, including financial guidance and projections; reorganizations, business plans, strategy and prospects; strategic reviews; capital allocation objectives; plans for and prospects of our acquisitions, dispositions and other business development activities, and our ability to successfully capitalize on these opportunities; manufacturing and product supply; our efforts to respond to COVID-19, including our COVID-19 products our expectations regarding the impact of COVID-19 on our business, operations and financial results; and other statements about our business, operations and financial results, that are subject to substantial risks and uncertainties that could cause actual results to differ materially from those expressed or implied by such statements. A description of these risks and uncertainties can be found in Pfizer’s Annual Report on Form 10-K for the fiscal year ended December 31, 2023 and in its subsequent reports on Form 10-Q, including in the sections thereof captioned “Risk Factors” and “Forward-Looking Information and Factors That May Affect Future Results”, as well as in its subsequent reports on Form 8-K, all of which are filed with the U.S. Securities and Exchange Commission and available at www.sec.gov and www.pfizer.com.

The forward-looking statements in the webcast speak only as of the original date of the webcast. Pfizer assumes no obligation to update forward-looking statements contained in the webcast as the result of new information or future events or developments.

Category: Finance

Media Contact:

PfizerMediaRelations@Pfizer.com

+1 (212) 733-1226

Investor Contact:

IR@Pfizer.com

+1 (212) 733-4848

Source: Pfizer Inc.

FAQ

When is Pfizer (PFE) presenting at the Morgan Stanley Healthcare Conference in 2024?

Pfizer (PFE) is presenting at the Morgan Stanley 22nd Annual Global Healthcare Conference on Wednesday, September 4, 2024, at 8:30 a.m. EDT.

Who will be representing Pfizer (PFE) at the 2024 Morgan Stanley Healthcare Conference?

David Denton, Chief Financial Officer and Executive Vice President of Pfizer (PFE), will be representing the company at the conference.

How can investors access Pfizer's (PFE) webcast for the 2024 Morgan Stanley Healthcare Conference?

Investors can access the webcast through Pfizer's website at www.pfizer.com/investors. Registration information will be available on the same page.

How long will the replay of Pfizer's (PFE) 2024 Morgan Stanley Healthcare Conference presentation be available?

The webcast replay and transcript will be accessible on Pfizer's website for at least 90 days after the live discussion.

What is Pfizer's (PFE) main focus as a biopharmaceutical company?

Pfizer (PFE) focuses on applying science and global resources to develop therapies that extend and improve lives, including innovative medicines and vaccines. They aim to set standards for quality, safety, and value in healthcare product development.

Pfizer Inc.

NYSE:PFE

PFE Rankings

PFE Latest News

PFE Stock Data

147.65B
5.66B
0.05%
67.83%
1.67%
Drug Manufacturers - General
Pharmaceutical Preparations
Link
United States of America
NEW YORK